TigerBao said:Hi all. As mentioned elsewhere, I'm a type 1 diabetic, treatment by insulin (humalog and lantus.)
My questions:
I can never remember the ideal before and after readings I should aim for. Is 6 -7 a good target to generally aim for at any time?
As a Type 1 your levels according to the NICE 2011 guidelines are this :
Fasting (waking)........between 4 - 7 mmol/l.
2 hrs after meals.......no more than 9 mmol/l.
What's the ideal hb1ac reading? My last test I think was last year and was something like 11.7, I know that's incredibly not good, but I don't know HOW incredibly not good (and yes I'm taking measures to get my thumb out of my orifice and take it back.)
NICE guidelines presently say 6.5% is good however it should be individually agreed with your HCP to suit your own circumstances.
And a not so quickie: Do you find that mood affects your sugars? I have, to put it PCly in this modern world, "emotional imbalances" and am often either angry or depressed, and I find when I can find nothing else at fault (I've injected the right amount, worked out how much I need, injected on time, etc) my being angry or otherwise "off" is often the only reason I can find for my sugars being off kilter.
It's actually the other way round.....'sugars' will affect your mood. It is well known that both high and low blood sugar levels will have an impact on your moods, aggressive, weepy, depressed etc........all sorts of effects.
Also related to the previous, does anyone know if antidepressants affect sugars? I was on zispin several years ago, which my doctor prescribed me, obviously, but the leaflet inside said it's not suitable for diabetics, coz they're made of sugar to dissolve on the tongue. Experiences shared would be appreciated. I don't want to go back on the antidepressants but lately my depression has been, well, winning.
Thanks everyone.
Tiger
increased appetite, weight gain, dry mouth; postural hypotension, peripheral oedema; drowsiness, fatigue, tremor, dizziness, abnormal dreams, confusion, anxiety, insomnia; arthralgia, myalgia; less commonly syncope, hypotension, mania, hallucinations, movement disorders; rarely myoclonus; very rarely blood disorders (see Cautions), convulsions, hyponatraemia (see Hyponatraemia and Antidepressant Therapy), suicidal behaviour (see Suicidal Behaviour and Antidepressant Therapy), and angle-closure glaucoma
cugila, I thought it was 7.5 from NICE, and 6.5 from DUK. If you have a link to the NICE stuff you got this from please would you post it? I'm collecting HbA1c recommendations for my study at present (they are all different!) and would be great if you could point me in the right direction for that figure. Ta.cugila said:NICE guidelines presently say 6.5% is good however it should be individually agreed with your HCP to suit your own circumstances.
Snodger said:cugila, I thought it was 7.5 from NICE, and 6.5 from DUK. If you have a link to the NICE stuff you got this from please would you post it? I'm collecting HbA1c recommendations for my study at present (they are all different!) and would be great if you could point me in the right direction for that figure. Ta.cugila said:NICE guidelines presently say 6.5% is good however it should be individually agreed with your HCP to suit your own circumstances.
Blood glucose control
Blood glucose control should be optimised towards attaining DCCT-harmonised HbA1c targets for
prevention of microvascular disease (less than 7.5%) and, in those at increased risk, arterial disease
(less than or equal to 6.5%) as appropriate, while taking into account:
• the experiences and preferences of the insulin user, in order to avoid hypoglycaemia
• the necessity to seek advice from professionals knowledgeable about the range of available
meal-time and basal insulins and about optimal combinations thereof, and their optimal use.
Advise that any improvement is beneficial, even if target HbA1c levels are not reached
(and the greater the improvement, the more the benefit)
Quality statement
People with diabetes agree with their healthcare professional a documented personalised HbA1c target, usually between 48 mmol/mol and 58 mmol/mol (6.5% and 7.5%), and receive an ongoing review of treatment to minimise hypoglycaemia.
Quality measure
Structure
Evidence of local arrangements to ensure that people with diabetes are able to agree with their healthcare professional a documented personalised HbA1c target, usually between 48 mmol/mol and 58 mmol/mol (6.5% and 7.5%), and receive an ongoing review of treatment to minimise hypoglycaemia.
Derived from the best available evidence such as NICE guidance and other evidence sources accredited by NHS Evidence, they are developed independently by NICE, in collaboration with the NHS and social care professionals, their partners and service users, and address three dimensions of quality: clinical effectiveness, patient safety and patient experience.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?